CYTO Income Statement


* In Millions (except for per share items) of CHF
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
Report Filing: 2024-04-10 2023-05-16 2022-04-12 2021-03-31 2020-04-16 2019-03-14 2018-03-22 2017-03-14 2016-03-14 2015-03-31 2013-12-31 2012-12-31
Revenue 0 305616 63882 174475 -56000 1266000 322000 -414000 -67000 3009000 0 0
Cost of Revenue 0 1443855 2240554 0 0 0 0 0 0 0 0 0
Gross Profit 0 -1138239 -2176672 174475 -56000 1266000 322000 -414000 -67000 3009000 0 0
Operating Expenses 5916099 24994240 14923121 5457641 7203144 12220123 24683251 29809275 30811000 25203000 14615849 4610503
Research & Development 3035413 19677756 8939037 2862979 3325281 6689589 19210842 24776763 26536000 17704000 13253638 3986691
Selling, General and Administrative 3123537 5903214 6394013 2594662 3933863 4264534 5150409 5412457 4342000 4489000 1312795 589528
Other Operating Expenses -242851 -586730 -409929 0 -56000 1266000 322000 -379945 -67000 3010000 49416 34284
Operating Income -5916099 -26132479 -17099793 -5283166 -7259144 -10954123 -24361251 -30223275 -30878000 -22194000 -14615849 -4610503
Net Interest(Non Operating) 730195 -910900 -186476 -134893 -10746 -1070177 -1586824 -760982 29000 2498 23859 5825
Interest Income 730195 969 3219 258 17882 0 53570 67565 37000 52133 74036 5825
Interest Expense 0 911869 189695 135151 28628 1070177 1640394 828547 8000 49635 50177 0
Equity & Other Income/(Expense) -2084134 504639 -82277 -2803390 444152 690076 1520828 190951 1144000 4006502 -106753 2269
Income Before Tax -7270038 -26538740 -17368546 -8221449 -6825738 -11334224 -24427247 -30793306 -29705000 -18185000 -14698743 -4602409
Income Tax Expense -1353939 -10329 21620 -21284 -193837 162177 -17773 -131055 -84777 -892177 305750 0
Income Attributable to Non-Controlling Interest 1353939 0 0 0 0 0 0 0 84777 892177 0 0
Net Income -7270038 -26528411 -17390166 -8200165 -6631901 -11496401 -24409474 -30662251 -29705000 -18185000 -15004493 -4602409
Depreciation and Amortization 5916099 119856 79576 258 17882 72713 122784 97600 92777 73984 37517 9242
EBITDA 0 -26012623 -17020217 -5282908 -7241262 -10881410 -24238467 -30125675 -30785223 -22120016 -14578332 -4601261
Earnings Per Share (EPS) -14.8 -29.13 -26.26 -27.27 -45.6 -289.2 -2232.23 -3572.86 -3679.09 -2626.75 -3324.73 -1019.81
Diluted Earnings Per Share -14.8 -29.13 -26.26 -27.27 -45.6 -289.2 -2232.23 -3572.86 -3679.09 -2626.75 -3324.73 -1019.81
Weighted Average Shares Outstanding 491258 910723 662314 300707 145452 39752 10935 8582 8074 6923 4513 4513
Diluted Weighted Average Shares Outstanding 491258 910723 662314 300707 145452 39752 10935 8582 8074 6923 4513 4513

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.